Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PANDA: Cefoxitin for Infection Prevention After Appendectomy
NCT06860802Phase 1Completed
- Sponsor
- University of Michigan
- Start
- Feb 2025
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial in surgical site infection (SSI) comparing Standard of Care with Cefoxitin (2 arms). Primary endpoint: Probability of Achieving Optimal Antibiotic Concentration in Appendix Tissue at 4 hours. Started Feb 2025; status: completed.
02
Drugs
cefoxitin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT06860802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06860802.